| Pharmaceutical active ingredients: |
| Nitrofurantoin |
| Available forms, composition and doses of Furadantin Retard: |
| Capsules, Retard; Oral; Nitrofurantoin 100 mg |
| Furadantin Retard medical category: |
| Human:AntibioticsUrinary anti-infectives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01XE01 - Nitrofurantoin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Boehringer IngelheimProcter & GambleVifor Pharma |
| Related documents and information about Furadantin Retard: |
| Furadantin prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Furacin-Sol | Nitrofurazone | Bioglan |
| Furacoccid | Nitrofurazone | Unidentified Pharmaceutical Company |
| Furacort | Nitrofurazone | Unidentified Pharmaceutical Company |
| Furacycline | Nitrofurazone | Unidentified Pharmaceutical Company |
| Furadantin | Nitrofurantoin | Elan Pharmaceuticals; Allphar Services; First Horizon Pharmaceutical; Formenti Farmaceutici; GlaxoSmithKline; Goldshield Pharmaceuticals; Nordend-Apotheke Dr. Wolfgang Hotz; Norwich Pharmaceuticals; Nycomed; Pfizer; Procter & Gamble; Recip, Sweden; Sciele Pharma; Shionogi |
| Furadantina | Nitrofurantoin | Boehringer Ingelheim; Normal Laboratorio; Schering-Plough |
| Furadantina MC | Nitrofurantoin | Boehringer Ingelheim |
| Furadantine | Nitrofurantoin | Merck; Procter & Gamble; Vifor Pharma |
| Furadantine MC | Nitrofurantoin macrocrystalline | Merck; Goldshield Pharmaceuticals |
| Furadantoin | Nitrofurantoin | Unidentified Pharmaceutical Company |